|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.82 USD | +0.33% |
|
+0.30% | +2.49% |
| 05-23 | Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical | MT |
| 05-22 | Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call |
Taro Pharmaceutical Industries Ltd. reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was USD 164.94 million compared to USD 146.59 million a year ago. Net income was USD 15.08 million compared to USD 6.91 million a year ago.
Basic earnings per share from continuing operations was USD 0.4 compared to USD 0.18 a year ago. Diluted earnings per share from continuing operations was USD 0.4 compared to USD 0.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.49% | 1.61B | |
| +40.73% | 739B | |
| +31.33% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.45% | 240B | |
| +9.21% | 210B | |
| -5.19% | 206B | |
| +6.17% | 164B |
TARO PHARMACEUTICAL INDUSTRIES LTD. 
